MELINTA THERAPEUTICS, INC. /NEW/
Profile
Company Names
MELINTA THERAPEUTICS, INC. /NEW/
CEMPRA, INC.
CEMPRA HOLDINGS, LLC
Addresses
300 GEORGE STREET, SUITE 301, NEW HAVEN, CT 06511
300 GEORGE STREET, SUITE 301, NEW HAVEN, CT 06511
6340 QUADRANGLE DRIVE, SUITE 100, CHAPEL HILL, NC 27517-8149
Phone Numbers
312 767 0291
312-767-0291
919-313-6617
919-313-6601
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY
Year Incorporated:
2008
State Incorporated:
DE
Total Amount Raised:
$346,816,282.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2018-01-05
$137,781,477.00
$137,781,477.00
$0.00
Equity
4
2017-11-03
$132,914,810.00
$132,914,810.00
$0.00
Equity
3
2012-10-24
$25,119,996.00
$25,119,996.00
$0.00
Equity
2
2011-08-05
$5,000,000.00
$5,000,000.00
$0.00
Debt
1
2009-05-13
$45,999,999.00
$46,000,000.00
$1.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
PRABHAVATHI
FERNANDES
EXECUTIVE OFFICER, DIRECTOR
KEVIN
FERRO
DIRECTOR
DAVID
GILL
DIRECTOR
CALYPSO MEDICAL TECHNOLOGIES INC
| CEMPRA, INC.
| ECPM HOLDINGS, LLC
| HISTOGENICS CORP
| MELINTA THERAPEUTICS, INC. /NEW/
| STRATA SKIN SCIENCES, INC.
| EVOLUS, INC.
| BIO2 TECHNOLOGIES, INC.
| PULSEON, INC.
| RAPIDPULSE, INC.
| MORPHOCEUTICALS, INC.
| PERIMETRICS, INC.
| 5 STAR RANCH, LLC
| BRIDGE TO LIFE LTD
DOV
GOLDSTEIN
DIRECTOR
CECILIA
GONZALO
DIRECTOR
JOHN
JOHNSON
DIRECTOR
ALIGN FINANCIAL GROUP, INC.
| CEMPRA HOLDINGS, LLC
| NATIONAL PLANNING CORP/CA
| CEMPRA, INC.
| GLUE NETWORKS, INC.
| NATIONAL MOLDING LLC
| CATALYTIC HOLDINGS, LLC
| HISTOGENICS CORP
| HIGHLAND COPPER CO INC.
| SNAP INFUSION LLC
| CORTENDO AB
| MERCER SONOCO INVESTMENT FUND, A SERIES OF MERCER GROUP TRUST
| MERCER ACTIVE LONG CORPORATE INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MERCER PHOENIX INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MERCER BUYOUT-READY FUND, A SERIES OF MERCER GROUP TRUST
| MERCER OFFICEMAX CONSOLIDATED INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MERCER OFFICEMAX SALARIED INVESTMENT PORTFOLIO, A SERIES OF MERCER GROUP TRUST
| MELINTA THERAPEUTICS, INC. /NEW/
| ROUNDPOINT MORTGAGE SERVICING CORP
| OPERATEMYBUILDING, INC.
| MIRATA PHARMACEUTICALS, LLC
| EVOLENT HEALTH, INC.
| HOSPITAL INNOVATIONS, LLC
| ENJOY EVERY SANDWICH LTD LIABILITY CO
| THEATRE OF THE UNIMPRESSED LTD LIABILITY CO
| ENJOY EVERY SARNIE LTD LIABILITY CO
| SECOND AVENUE JAMBOREE LTD LIABILITY CO
| STEREOPHONIC UK LTD LIABILITY CO
| SEVEN ROADS TOUR LTD LIABILITY CO
| FACE SPLIT OPEN LTD LIABILITY CO
| SHOW BIZ, ITS JUST SHOW BIZ LTD LIABILITY CO
| INTER ALIA BROADWAY LTD LIABILITY CO
JOHN
H.
JOHNSON
DIRECTOR
RICHARD
KENT
DIRECTOR
CEMPRA HOLDINGS, LLC
| ALDAGEN INC
| CSA MEDICAL INC
| CYTOMEDIX INC
| ESANEX, INC.
| CEMPRA, INC.
| VASCULAR PHARMACEUTICALS, INC.
| AVISTONE NORTH HIGHLANDS, LLC
| INNOCRIN PHARMACEUTICALS HOLDINGS, LLC
| CSA MEDICAL, INC.
| BARINGS GLOBAL CREDIT FUND (LUX) SCSP, SICAV-SIF
| BARINGS REAL ESTATE EUROPEAN VALUE ADD FUND II, A SUB-FUND OF BARINGS UMBRELLA FUND (LUX) SCSP SICAV-RAIF
| BARINGS EUROPEAN REAL ESTATE DEBT INCOME FUND, A SUB-FUND OF BARINGS UMBRELLA FUND (LUX) SCSP SICAV-RAIF
| AVISTONE TULSA, LLC
GARHENG
KONG
DIRECTOR
CEMPRA HOLDINGS, LLC
| APPLIED GENETIC TECHNOLOGIES CORP
| VIAMET PHARMACEUTICALS INC
| ALDAGEN INC
| TRANSENTERIX INC
| CANCERGUIDE DIAGNOSTICS, INC.
| SARCODE BIOSCIENCE INC.
| SOFINNOVA VENTURE PARTNERS VIII, L.P.
| HISTOGENICS CORP
| CEMPRA, INC.
| ALIMERA SCIENCES INC
| FIRST AID BEVERAGES, INC.
| SOFINNOVA HEALTHQUEST PARTNERS, L.P.
| TRICE MEDICAL, INC.
| LONGWOOD OPPORTUNITY OFFSHORE FUND, LTD
| LONGWOOD OFFSHORE, LTD.
| CASTLE BIOSCIENCES INC
| STRONGBRIDGE BIOPHARMA PLC
| ACUTA OPPORTUNITY OFFSHORE FUND, LTD.
| ACUTA CAPITAL OFFSHORE FUND, LTD.
| HEALTHQUEST PARTNERS II, L.P.
| MAGNOLIA MEDICAL TECHNOLOGIES, INC.
| VENUS CONCEPT LTD.
| ALCRESTA THERAPEUTICS, INC.
| MELINTA THERAPEUTICS, INC. /NEW/
| AVEDRO INC
| CLEANSLATE CENTERS, INC.
| BARDY DIAGNOSTICS, INC.
| HEALTHQUEST PARTNERS III, L.P.
| HEALTHQUEST AJAX II SPV, L.P.
| AJAX HEALTH II LLC
| VENUS CONCEPT INC.
| HEALTHQUEST AJAX III SPV, L.P.
| AJAX HEALTH III LLC
| HEALTHQUEST AJAX III-A SPV, L.P.
| HEALTHQUEST MADISON SPV, L.P.
| HEALTHQUEST PARTNERS IV, L.P.
| HEALTHQUEST TACTICAL OPPORTUNITIES FUND, L.P.
| HOME HOSPITAL NEWCO, INC.
| HQTOF ENDEAVOR SPV, L.P.
| HQTOF ENDEAVOR SPV-B, L.P.
| NOMAD HEALTH, INC.
GEETA
VEMURI
DIRECTOR
ARGINETIX, INC.
| CEMPRA HOLDINGS, LLC
| CORRIDOR PHARMACEUTICALS, INC.
| GLIKNIK INC
| SYNTIMMUNE, INC.
| ONCORESPONSE INC
| AGENT CAPITAL FUND I LP
| PYXIS ONCOLOGY, INC.
| AGENT CAPITAL FUND II, LP
| VITTORIA BIOTHERAPEUTICS, INC.
| CARBON BIOSCIENCES, INC.
| CANTAI THERAPEUTICS, INC.
| AGENT CAPITAL FUND III LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-01-05
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-11-03
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-10-24
